| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |